In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a C17H15ClN4S Drug Master File in Korea (C17H15ClN4S KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of C17H15ClN4S. The MFDS reviews the C17H15ClN4S KDMF as part of the drug registration process and uses the information provided in the C17H15ClN4S KDMF to evaluate the safety and efficacy of the drug.
After submitting a C17H15ClN4S KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their C17H15ClN4S API can apply through the Korea Drug Master File (KDMF).
click here to find a list of C17H15ClN4S suppliers with KDMF on PharmaCompass.